Free Trial

Organigram Q4 2024 Earnings Report

Organigram logo
$1.55 -0.02 (-1.27%)
As of 01/17/2025 04:00 PM Eastern

Organigram EPS Results

Actual EPS
-$0.04
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Q4 2024
Time
Before Market Opens

Organigram Earnings Headlines

Organigram (NASDAQ:OGI) Stock Price Down 1.3% - Time to Sell?
Organigram reports Q4 revenue C$44.7M vs. C$36.7M last year
Stunning Trump Exec Order Leaked
Most people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... This could be the most important building in America.
Organigram’s Strong Fiscal Growth and Market Leadership
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (NASDAQ:OGI), through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

View Organigram Profile

More Earnings Resources from MarketBeat